Skye Bioscience, Inc. Annual Operating Income (Loss) in USD from 2012 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Skye Bioscience, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2012 to 2023.
  • Skye Bioscience, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$4.97M, a 79.9% increase year-over-year.
  • Skye Bioscience, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$23.6M, a 40.9% increase year-over-year.
  • Skye Bioscience, Inc. annual Operating Income (Loss) for 2023 was -$34.7M, a 89.7% decline from 2022.
  • Skye Bioscience, Inc. annual Operating Income (Loss) for 2022 was -$18.3M, a 133% decline from 2021.
  • Skye Bioscience, Inc. annual Operating Income (Loss) for 2021 was -$7.85M, a 24.8% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$34.7M -$16.4M -89.7% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-22
2022 -$18.3M -$10.5M -133% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-22
2021 -$7.85M -$1.56M -24.8% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 -$6.29M +$344K +5.18% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-28
2019 -$6.63M -$1.94M -41.3% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-02
2018 -$4.69M -$833K -21.6% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-23
2017 -$3.86M +$611K +13.7% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-14
2016 -$4.47M -$153K -3.56% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-19
2015 -$4.32M -$1.59M -58% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-10
2014 -$2.73M -$2.61M -2169% Jan 1, 2014 Dec 31, 2014 10-K 2016-03-21
2013 -$120K -$125K -3025% Jan 1, 2013 Dec 31, 2013 10-K 2015-03-27
2012 $4.12K Nov 1, 2011 Oct 31, 2012 10-K 2014-01-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.